This CFS report assesses a range of concerns associated with Ventria’s development of rice genetically engineered as a “biofactory” for production of recombinant human proteins with putative pharmaceutical properties.
ALL RIGHTS RESERVED. This material is protected under International and Federal Copyright Laws and Treaties. Any unauthorized reprint or use of this material is prohibited. No text may be reproduced or transmitted in any form or by any means without express written permission or proper citation. Please credit any and all use of our work product to: Center for Food Safety, www.centerforfoodsafety.org.